Since it is known that MMP-7 is localized at invasive front in colon cancer cells, syndecan-2 could immobilize pro-MMP-7 to restrict its range of action and regulate the processing of pro-MMP-7 to further regulate degradation of ECM and cell adhesion molecules. Here, MMP7 is linked to malignant colon neoplasm.